Found: 14
Select item for more details and to access through your institution.
OA03 Are there any differences in the outcomes of treatment of a 12-month course of rituximab BCD020 biosimilar in systemic lupus erythematosus in children with early and late administration of the drug.
- Published in:
- Rheumatology, 2023, v. 62, p. 1, doi. 10.1093/rheumatology/kead323.003
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
A124: Hepcidin as a Predictor of Evolution of Anemia of Chronic Disease to a Macrophage Activation Syndrome in Children With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S162, doi. 10.1002/art.38545
- By:
- Publication type:
- Article
A128: Hierarchical Clustering Methodology for Exploration of Proteomic Profile in Tears: Seeking for Markers of Uveitis Associated With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S168, doi. 10.1002/art.38549
- By:
- Publication type:
- Article
A130: Is the CCR5-delta32 Mutation Protective Against Systemic-Onset Juvenile Idiopathic Arthritis?
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S171, doi. 10.1002/art.38551
- By:
- Publication type:
- Article
A98: Rescue Treatment by Increased Doses of IL-1 Inhibitors for Macrophage Activation Syndrome in Children With Systemic Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S133, doi. 10.1002/art.38515
- By:
- Publication type:
- Article
A87: Different Tocilizumab Therapeutic Protocols and Possibility Achieving Tocilizumab-Off Remission in Systemic Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S120, doi. 10.1002/art.38503
- By:
- Publication type:
- Article
Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children.
- Published in:
- Children, 2023, v. 10, n. 8, p. 1366, doi. 10.3390/children10081366
- By:
- Publication type:
- Article
Using HScore for Evaluation of Hemophagocytosis in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children.
- Published in:
- Biomedicines, 2024, v. 12, n. 2, p. 294, doi. 10.3390/biomedicines12020294
- By:
- Publication type:
- Article
Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study.
- Published in:
- Biomedicines, 2023, v. 11, n. 5, p. 1503, doi. 10.3390/biomedicines11051503
- By:
- Publication type:
- Article
COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 870, doi. 10.3390/biomedicines11030870
- By:
- Publication type:
- Article